¶ AIM at Melanoma Foundation
.png)
The AIM at Melanoma Foundation is an American nonprofit organization based in Frisco, Texas.
¶ History
In the first quarter of 2021, the foundation received a $10,000 grant from Pfizer for a project titled “From the Clinic to the Living Room.”[1]
¶ Organization
AIM at Melanoma is a partner of the Society for Immunotherapy of Cancer.[2]
¶ Sponsors
The foundation is sponsored by:[3]
- Alkermes
- Amgen
- BioAlta
- BioNTech
- Bristol-Myers Squibb (BMS)
- Caris Life Sciences
- Castle Biosciences
- Checkmate Pharmaceuticals
- Genentech
- Immunocore
- InstilBio
- IO Biotech
- Iovance Biotherapeutics
- Istari
- Merck
- Myriad Genetics
- Natera
- Novartis
- Oncosec Immunotherapies
- Pfizer
- Pierre Fabre
- Regeneron Pharmaceuticals
- Replimune
- Roche
- Sanofi Genzyme
¶ External links
US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021. (2021, September 27). Pfizer. https://web.archive.org/web/20230503211316/https://s3.documentcloud.org/documents/23787007/pfizer-2021-report.pdf ↩︎
Cancer Immunotherapy Partnerships and Collaborations. Society for Immunotherapy of Cancer. Retrieved March 27, 2023, from https://web.archive.org/web/20230327191240/https://www.sitcancer.org/aboutsitc/partnerships#champions ↩︎
Our Industry Partners. AIM at Melanoma Foundation. Retrieved May 10, 2023, from https://web.archive.org/web/20230510200316/https://www.aimatmelanoma.org/our-industry-partners/ ↩︎